Skip to main content
Clinical Trials/ACTRN12616000697482
ACTRN12616000697482
Active, not recruiting
未知

Effect of percutaneous endoscopic gastrostomy (PEG) tube feeding on nutritional status in patients undergoing chemoradiotherapy for esophageal cancer

Instituto Portugues de Oncologia de Lisboa Francisco Gentil0 sites29 target enrollmentMay 26, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Esophageal cancer
Sponsor
Instituto Portugues de Oncologia de Lisboa Francisco Gentil
Enrollment
29
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Instituto Portugues de Oncologia de Lisboa Francisco Gentil

Eligibility Criteria

Inclusion Criteria

  • Patients with esophagus cancer (squamous cell carcinoma and adenocarcinoma) and esophageal\-gastric junction cancer, Siewert I, (adenocarcinoma) with dysphagia (grade\> 2\) and/or weight loss (\> 10% normal body weight), proposed for definitive or neoadjuvant CRT

Exclusion Criteria

  • Contraindications for PEG placement:
  • \- patients with no ability to take care of PEG,
  • \- decompensated chronic liver disease,
  • \- presence of clinically significant ascites.

Outcomes

Primary Outcomes

Not specified

Similar Trials